Coeptis Therapeutics logo

Coeptis Therapeutics Share Price Today

(NASDAQ: COEP)

Coeptis Therapeutics share price is $10.8 & ₹939.27 as on 6 Mar 2025, 2.30 'hrs' IST

$10.8

-0.2

(-1.82%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Coeptis Therapeutics share price in Dollar and Rupees. Guide to invest in Coeptis Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Coeptis Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Coeptis Therapeutics share price movements

  • Today's Low: $10.62
    Today's High: $11.00

    Day's Volatility :3.45%

  • 52 Weeks Low: $2.31
    52 Weeks High: $13.70

    52 Weeks Volatility :83.14%

Coeptis Therapeutics (COEP) Returns

PeriodCoeptis Therapeutics Holdings IncIndex (Russel 2000)
3 Months
176.21%
0.0%
6 Months
191.89%
0.0%
1 Year
0.19%
0.0%
3 Years
-84.12%
-11.6%

Coeptis Therapeutics (COEP) Key Statistics

in dollars & INR

Previous Close
$11.0
Open
$10.62
Today's High
$11.0
Today's Low
$10.62
Market Capitalization
$8.1M
Today's Volume
$10.5K
52 Week High
$13.7
52 Week Low
$2.31
Revenue TTM
$0.0
EBITDA
$-16.0M
Earnings Per Share (EPS)
$-0.47
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1481.29%

How to invest in Coeptis Therapeutics Stock (COEP) from India?

It is very easy for Indian residents to invest directly in Coeptis Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Coeptis Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Coeptis Therapeutics or COEP on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Coeptis Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Coeptis Therapeutics shares which would translate to 0.081 fractional shares of Coeptis Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Coeptis Therapeutics, in just a few clicks!

Returns in Coeptis Therapeutics (COEP) for Indian investors in Rupees

The Coeptis Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Coeptis Therapeutics investment value today

Current value as on today

₹1,05,134

Returns

₹5,134

(+5.13%)

Returns from Coeptis Therapeutics Stock

₹186 (+0.19%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Coeptis Therapeutics (COEP)

-72%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Coeptis Therapeutics Stock from India on INDmoney has decreased by -72% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Coeptis Therapeutics

  • UBS Group AG

    0.01%

Analyst Recommendation on Coeptis Therapeutics

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Coeptis Therapeutics(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Coeptis Therapeutics Stock (COEP)

What analysts predicted

Downside of 72.22%

Target:

$3.00

Current:

$10.80

Insights on Coeptis Therapeutics Stock (Ticker Symbol: COEP)

  • Price Movement

    In the last 3 months, COEP stock has moved up by 195.9%
  • COEP vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 66.3%
  • COEP vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 135.5%

Coeptis Therapeutics Technicals Summary

Sell

Neutral

Buy

Coeptis Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Coeptis Therapeutics (COEP) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Coeptis Therapeutics Holdings Inc logo
-10.6%
191.89%
0.19%
-84.12%
-86.67%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Coeptis Therapeutics Holdings Inc logo
NA
NA
NA
0.0
-14.81
-1.87
NA
-0.01
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Coeptis Therapeutics Holdings Inc logo
Buy
$8.1M
-86.67%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Coeptis Therapeutics

Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical company. It is developing cell therapy platforms for cancer, autoimmune, and infectious diseases that have the potential to disrupt conventional treatment paradigms and improve patient outcomes. Its product portfolio and rights are licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, natural killer cell therapy technology. The company is also developing a multi-antigen CAR T technology licensed from the University of Pittsburgh, and the GEAR cell therapy and companion diagnostic platforms, which are developing with VyGen-Bio and medical researchers at the Karolinska Institute. Its Product Pipeline consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company also offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.
Organization
Coeptis Therapeutics
Employees
5
CEO
Mr. David Mehalick
Industry
Miscellaneous

Management People of Coeptis Therapeutics

NameTitle
Mr. David Mehalick
Co-Founder, Chairman of the Board, CEO & President
Ms. Christine Elise Sheehy
Co-Founder and VP of Compliance & Corporate Secretary
Mr. Daniel Alexander Yerace
Co-Founder, VP of Operations & Director
Mr. Brian Cogley M.B.A.
Chief Financial Officer
Dr. Colleen Delaney M.D., M.Sc.
CSO & Chief Medical Officer

Important FAQs about investing in COEP Stock from India :

What is Coeptis Therapeutics share price today?

Coeptis Therapeutics share price today stands at $10.80, Open: $10.62 ; Previous Close: $11.00 ; High: $11.00 ; Low: $10.62 ; 52 Week High: $13.70 ; 52 Week Low: $2.31.

The stock opens at $10.62, after a previous close of $11.00. The stock reached a daily high of $11.00 and a low of $10.62, with a 52-week high of $13.70 and a 52-week low of $2.31.

Can Indians buy Coeptis Therapeutics shares?

Yes, Indians can invest in the Coeptis Therapeutics (COEP) from India.

With INDmoney, you can buy Coeptis Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Coeptis Therapeutics at zero transaction cost.

How can I buy Coeptis Therapeutics shares from India?

It is very easy to buy Coeptis Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Coeptis Therapeutics (COEP) be purchased?

Yes, you can buy fractional shares of Coeptis Therapeutics with INDmoney app.

What are the documents required to start investing in Coeptis Therapeutics stocks?

To start investing in Coeptis Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Coeptis Therapeutics Stock (COEP)?

Today’s highest price of Coeptis Therapeutics (COEP) is $11.00.

Today’s lowest price of Coeptis Therapeutics (COEP) is $10.62.

What is today's market capitalisation of Coeptis Therapeutics?

Today's market capitalisation of Coeptis Therapeutics COEP is 8.1M

What is the 52 Week High and Low Range of Coeptis Therapeutics Stock (COEP)?

  • 52 Week High

    $13.70

  • 52 Week Low

    $2.31

What are the historical returns of Coeptis Therapeutics (COEP)?

  • 1 Month Returns

    -10.6%

  • 3 Months Returns

    191.89%

  • 1 Year Returns

    0.19%

  • 5 Years Returns

    -86.67%

Who is the Chief Executive Officer (CEO) of Coeptis Therapeutics ?

Mr. David Mehalick is the current Chief Executive Officer (CEO) of Coeptis Therapeutics.